7th Glioblastoma Drug Development Summit
-
Location:
- The Royal Sonesta Boston
- 40 Edwin H Land Boulevard
- Cambridge
- Massachusetts
- 02142
- United States
- View on a map
- More Information:
-
Contact:
- Organiser: Hanson Wade
- Name: Hanson Wade
- Email: info@hansonwade.com
- Telephone: +16174554188
Innovating Novel Combination Therapies and Maximising Preclinical and Clinical Development to Improve Glioblastoma Targeting and Increase Investment Opportunities to Ultimately Bring Efficacious Therapies to Patients in Need
The glioblastoma drug development space has been energized by Merck's acquisition of Modifi Bio last December. This landmark deal has sparked renewed hope in a field long challenged by limited investment and clinical breakthroughs.
Looking ahead to 2026, it's crucial to sustain this momentum. The 7th Glioblastoma Drug Development Summit is your essential platform for accelerating new treatments and continuing this vital progress.
Join us for a definitive, 3-day summit designed to accelerate progress. With groundbreaking content and six deep-dive workshops, you'll connect with over 90 leading experts from every corner of the field - from biotech to investment. This is your opportunity to uncover the latest advancements, learn how to overcome funding challenges, and explore the transformative role of AI in glioblastoma.
Together, we'll unlock actionable insights, forge powerful partnerships, and secure the future of your pipeline and move towards the delivery of transformative therapies for one of the most devastating and underserved cancers.
Date and Time: Tuesday, 17 February 2026 at 08:30 - Thursday, 19 February 2026 at 17:30
